Results 101 to 110 of about 77,789 (337)

Effect of nitroprusside on furosemide-induced skeletal teratogenicity in rat fetuses

open access: yesIranian South Medical Journal, 2016
Background: Furosemide as a loop diuretic can use in treatment of hypertension, renal or heart failures and cirrhosis, when sodium retention is significant.
Mahmood Khaksary Mahabady   +2 more
doaj  

Short‐Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study

open access: yesJournal of Veterinary Internal Medicine, 2017
Background Furosemide is the only loop diuretic recommended by the ACVIM consensus guidelines for treatment of congestive heart failure (CHF) in dogs related to degenerative mitral valve disease (DMVD).
Valérie Chetboul   +10 more
semanticscholar   +1 more source

Pulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach [PDF]

open access: gold, 2021
José Santos   +12 more
openalex   +1 more source

Prophylactic furosemide infusion decreasing early major postoperative renal dysfunction in on-pump adult cardiac surgery: a randomized clinical trial

open access: yes, 2017
Solmaz Fakhari,1 Fariba Mirzaei Bavil,2 Eissa Bilehjani,1 Sona Abolhasani,3 Moussa Mirinazhad,2 Bahman Naghipour2 1Department of Anesthesiology, 2Department of Physiology, 3Tabriz University of Medical Sciences, Tabriz, Iran Introduction: Acute ...
Bilehjani E   +5 more
core  

Cardiac resynchronization therapy and pulmonary artery banding in advanced heart failure infants with left ventricular dilated cardiomyopathy and left bundle branch block

open access: yesPediatric Investigation, EarlyView.
The combination of cardiac resynchronization therapy and pulmonary artery banding was associated with substantial improvement in advanced heart failure infants with left ventricular dilated cardiomyopathy and left bundle branch block. Most patients exhibited marked improvement in clinical status and ventricular function, along with a reduction in QRS ...
Min Zeng   +8 more
wiley   +1 more source

Medication prescription patterns in cancer rehabilitation physiatry outpatients: A multicenter retrospective study

open access: yesPM&R, EarlyView.
Abstract Background and Objective Previous work from this dataset found 45% prescribing frequency of any medications (35.1%, 33.5%, and 56.8% at institutions 1, 2, and 3 respectively), without significant difference between in‐person and telemedicine.
Matthew Chen   +7 more
wiley   +1 more source

Development and characterization of furosemide-loaded binary amorphous solid dispersion to enhance solubility and dissolution for pediatric oral administration [PDF]

open access: yesPharmacia
Binary co-amorphous systems, as solid dispersions of an active pharmaceutical ingredient with low molecular weight excipients, improve solubility, physical stability, and bioavailability relative to crystalline forms.
Mays Fadhil Mohammed-Kadhum   +1 more
doaj   +3 more sources

AMPKα Silencing Prevents Kanamycin‐Induced Ototoxicity in an Acute Mouse Model

open access: yesSensory Neuroscience, EarlyView.
Kanamycin plus furosemide (KM + FU) treatment (acute ototoxic model) causes AMPKα activation and rapidly induces cochlear outer hair cell (OHC) loss. Silencing AMPKα1 via posterior semicircular canal injection 48 h before KM + FU treatment reduces this damage, preserving OHCs and hearing.
Shengyu Zou   +6 more
wiley   +1 more source

Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure

open access: yesESC Heart Failure, 2016
Loop diuretics are first‐line medications for congestive heart failure (CHF); however, they are associated with serious adverse effects, including decreased renal function, and sympathetic nervous and renin–angiotensin system activation.
K. Jujo   +9 more
semanticscholar   +1 more source

Effects of combined gentamicin and furosemide treatment on cochlear ribbon synapses

open access: hybrid, 2021
Liana Sargsyan   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy